Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.
Telix Pharmaceuticals is seeking a Medical Writer to support the international rollout of their prostate cancer imaging agent and advance their late-stage product portfolio. The role involves writing and editing regulatory documents, analyzing data, and collaborating with various teams to ensure product development is aligned with regulatory guidelines and clinical needs. This is an in-person role based in Canada.
Telix Pharmaceuticals Limited is a biopharmaceutical company headquartered in Melbourne, Australia, with operations in the US, Europe, and Japan. The company specializes in developing therapeutic and diagnostic radiopharmaceuticals, targeting significant unmet needs in oncology and rare diseases. Telix's key value propositions include its focus on theranostics, molecularly targeted radiation, and advanced imaging technologies, positioning it as a leader in the field of nuclear medicine.